Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis
Authors
Keywords
-
Journal
HAEMOPHILIA
Volume 24, Issue 2, Pages 245-252
Publisher
Wiley
Online
2018-02-13
DOI
10.1111/hae.13413
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A
- (2017) A. D. Shapiro et al. HAEMOPHILIA
- Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
- (2017) K. John Pasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emicizumab Prophylaxis in Hemophilia A with Inhibitors
- (2017) Johannes Oldenburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX
- (2017) Angiola Rocino et al. Journal of Clinical Medicine
- Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
- (2016) Sriram Krishnamoorthy et al. CELLULAR IMMUNOLOGY
- Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study
- (2016) V. Jiménez-Yuste et al. HAEMOPHILIA
- Extended half-life factor VIII for immune tolerance induction in haemophilia
- (2016) L. M. Malec et al. HAEMOPHILIA
- The past and future of haemophilia: diagnosis, treatments, and its complications
- (2016) Flora Peyvandi et al. LANCET
- Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein
- (2016) Charles L. Groomes et al. PEDIATRIC BLOOD & CANCER
- The burden of inhibitors in haemophilia patients
- (2016) Christopher Walsh et al. THROMBOSIS AND HAEMOSTASIS
- US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors
- (2015) L. A. Valentino et al. HAEMOPHILIA
- Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors
- (2015) V. Jiménez-Yuste et al. HAEMOPHILIA
- Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two US centres
- (2015) C. Nakar et al. HAEMOPHILIA
- First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study
- (2015) W. Kreuz et al. HAEMOPHILIA
- Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A
- (2015) B. Nolan et al. HAEMOPHILIA
- Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study
- (2015) A. Antun et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A
- (2015) G. Young et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Regulation of immune responses to protein therapeutics by transplacental induction of T cell tolerance
- (2015) Nimesh Gupta et al. Science Translational Medicine
- New predictive approaches for ITI treatment
- (2014) G. D. Minno et al. HAEMOPHILIA
- Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
- (2013) J. Mahlangu et al. BLOOD
- Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate
- (2013) J. Oldenburg et al. HAEMOPHILIA
- Modern haemophilia care
- (2012) Erik Berntorp et al. LANCET
- The principal results of the International Immune Tolerance Study: a randomized dose comparison
- (2011) C. R. M. Hay et al. BLOOD
- Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans?
- (2010) M. U. CALLAGHAN et al. HAEMOPHILIA
- Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors
- (2009) A. COPPOLA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- How we treat a hemophilia A patient with a factor VIII inhibitor
- (2008) C. L. Kempton et al. BLOOD
- Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"
- (2008) A. S. De Groot et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started